Overweight: Clinical Trials

2 trials for Overweight, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 suspended. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Suspended 2

Follow Overweight: new trials by email Literature Review of Overweight trials Research Report on Overweight

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects With NASH (ARMOR)
Aramchol free acid, Placebo - Nonalcoholic Steatohepatitis (NASH)
Phase 3SuspendedGalmed Research and Development, Ltd.1572019-09-232026-02-11
Acetaminophen Dosing in Obese Adolescents
Tylenol - Obesity, Childhood
Phase 3SuspendedChildren's National Research Institute62016-08-012024-08-22

Narrower conditions

Obesity (2)  ·  Diabetes Mellitus (1)  ·  Fibrosis (1)  ·  Liver Cirrhosis (1)  ·  Non-alcoholic Fatty Liver Disease (1)  ·  Pediatric Obesity (1)

Broader conditions

Body Weight (2)  ·  Nutrition Disorders (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Overnutrition (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Digestive System Diseases (1)  ·  Endocrine System Diseases (1)  ·  Fatty Liver (1)  ·  Glucose Metabolism Disorders (1)  ·  Liver Diseases (1)  ·  Metabolic Diseases (1)  ·  Pathologic Processes (1)

Interventions

Acetaminophen (1)

Sponsors

Children's National Research Institute (1)  ·  Galmed Research and Development, Ltd. (1)

Countries

United States (2)

Top investigators

Yossi Gilgun-Sherki, PhD, MBA (1)

Results publications

PMID 12434728, PMID 18987268, PMID 22253363, PMID 22253364, PMID 22389380, PMID 22768009, PMID 38916482, PMID 8403734, PMID 9874695